Paul Bisaro, EC, Director at Amneal Pharmaceuticals, holds 97.44K shares in Myriad Genetics (Ticker: MYGN), holds 27.86K shares in Zoetis (Ticker: ZTS), holds 32.05K shares in Mallinckrodt public limited company (Ticker: MNKTQ). Most recently, Paul Bisaro Bought ― shares of Myriad Genetics on May 14, 2026 for an estimated value of $27.60K.
Paul Bisaro latest transaction was an Informative Buy of $27.60K.
What was Paul Bisaro's most profitable transaction?
Paul Bisaro’s most profitable transaction was an Informative Buy of ZTS stock on May 13, 2026. The return on the trade was -0.10%.
What is Paul Bisaro's role in Amneal Pharmaceuticals?
Paul Bisaro's role in Amneal Pharmaceuticals is EC, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.